Skip to content

Memantine

Also called Namenda — an uncompetitive open-channel NMDA receptor antagonist

A low to moderate affinity uncompetitive open-channel NMDA receptor antagonist, which means it can only enter a channel glutamate has already opened and leaves again quickly.

  • TypeSmall molecule
  • FormOral
  • Researched forCognitive & Mood

Where to get Memantine

RUPharma
Oral
Code CAMERON

Sold as the form named. Approved uses are on its label; the research here goes beyond them.

Shop oral at RUPharma
Before you run this, know your numbers

Approved for moderate-to-severe Alzheimer's dementia. Its own label does not claim it changes the course of the disease.

About half of it leaves the body unchanged through the kidney, and the label lowers the target dose in severe renal impairment. That makes kidney function the number that decides the dose — and it is a number most people have never looked at.

Order these through my Marek link

The short version

  • Why people research itFocus, memory, neuroprotection, mood and stress resilience.
  • What the evidence isApproved for moderate to severe Alzheimer's dementia, and that is the whole indication — not mild disease, not age-related forgetfulness.
  • What to watchNew hallucinations, agitation or confusion.

How Memantine works

The mechanism is a filter, not a switch, and the whole drug follows from that. The label states it plainly: memantine acts as a low to moderate affinity uncompetitive open-channel NMDA receptor antagonist Memantine label 2025.

What it is approved for, and it is narrower than the shelf it is sold on. The indication is moderate to severe dementia of the Alzheimer's type Memantine label 2025. Not mild.

That combination blocks the steady background leak of a chronically over-activated receptor while stepping aside for the brief bursts that carry a signal. It is the only widely used dementia drug acting on the glutamate side rather than by raising acetylcholine, which is why it is studied in combination with the cholinesterase inhibitors rather than against them.

  • Oral

On the goal map: Glutamatergic & synaptic plasticity (Focus, memory & cognition)

Research on Memantine7 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Approved for moderate to severe Alzheimer's dementia. In the largest pooled dataset it did not reach the reviewers' own threshold for a clinically important effect as a single agent.

Human clinical evidence

  • Approved for moderate to severe Alzheimer's dementia, and that is the whole indication — not mild disease, not age-related forgetfulness. An individual-patient network meta-analysis of 80 randomized trials in 21,138 adults set 1.40 MMSE points as its threshold for a clinically important difference and reports that every regimen cleared it EXCEPT single-agent rivastigmine, galantamine and memantine (Veroniki 2022).

  • A 2026 Bayesian network meta-analysis of 125 trials in more than 30,000 people put memantine at a standardized mean difference of 0.24 and donepezil at 0.21 — while aerobic exercise scored 0.55 and cognitive training 0.45 in the same network (Li 2026). The authors are careful that the non-drug arms are short-term and adjunctive rather than substitutes.

  • Nobody has ever tested it in cognitively normal adults. Every participant in both syntheses carried a dementia diagnosis.

Correlative data

  • The Cochrane review of stopping these drugs pooled six trials and 759 participants and states that no trial assessed withdrawal of memantine alone (Parsons 2021). Anyone starting it without a prescriber has no published basis for deciding when or how to stop.

  • The 2025 dementia guideline recommends it strongly for moderate to severe Alzheimer's disease and separately from the cholinesterase inhibitors, because it acts on a different transmitter system (Kim 2025).

How the mechanism reads

  • A low-to-moderate affinity uncompetitive open-channel NMDA antagonist: it can only enter a channel glutamate has already opened and leaves again quickly, which blocks a chronic background leak while stepping aside for signal-carrying bursts.

    Mechanistic
  • The interaction nobody warns this audience about. Its label states renal clearance falls about 80% under alkaline urine at pH 8. Sodium bicarbonate loading before hard intervals does exactly that, on a drug with a 60-80 hour half-life — so the result is accumulation, and the presentation of too much of it is confusion.

    Mechanistic

Sources

Memantine safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Severe kidney impairment: it is cleared by the kidney and builds up.
  • Seizure history: NMDA blockers can lower seizure threshold in some people.
  • Taking dextromethorphan, ketamine or amantadine: other NMDA blockers stack side effects.
  • Urine alkalinizing agents or very alkaline urine: they slow its clearance.
  • Pregnancy or breastfeeding: NMDA blockade in a developing brain is untested.

What’s expected

  • Dizziness or light confusion early, from open-channel NMDA blockade.
  • Headache, constipation or sleepiness in the first weeks.
  • Smoothing of background mental noise rather than a stimulant effect.

Watch for

  • New hallucinations, agitation or confusion.
  • A seizure or fainting spell.
  • Marked swelling, breathlessness or very slow heartbeat.
  • Passing little or no urine.

Labs that tell you it’s working

  • Cystatin C with eGFR
  • Comprehensive Metabolic Panel (CMP)
  • Vitamin B12 & Folate
  • Urinalysis, Routine

Low-affinity uncompetitive NMDA channel blocker cleared by the kidney, so kidney function and urine pH set exposure.

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

Memantine FAQ4 common questions

Is Memantine approved for human use?
Memantine is an approved medicine for the uses on its label. This page covers research beyond those uses, as education, not medical advice.
What is Memantine researched for?
Focus, memory, neuroprotection, mood and stress resilience.
Which labs show whether it's doing anything?
Cystatin C with eGFR; Comprehensive Metabolic Panel; Vitamin B12 & Folate; Urinalysis, Routine: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Memantine: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Memantine is. Skool covers how it is run.

Free on this page

What Memantine is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Memantine is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool